The SARS-CoV-2 pandemic has impacted public health systems all over the world. The Delta variant seems to possess enhanced transmissibility, but no clear evidence suggests it has increased virulence. Our data show that pre-exposed individuals had similar neutralizing activity against the authentic COVID-19 strain and the Delta and Epsilon variants. After only one vaccine dose, the neutralization capacity expanded to all tested variants in pre-exposed individuals. Healthy vaccinated individuals showed a limited breadth of neutralization. One vaccine dose did induce similar neutralizing antibodies against the Delta as against the authentic strain. However, even after two doses, this capacity only expanded to the Epsilon variant
The Delta variant raised concern regarding its ability to evade SARS-CoV-2 vaccines. We evaluated a ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...
International audienceThe SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,...
Introduction: COVID-19 vaccines have been developed to compact the current SARS-CoV-2 pandemic and h...
Background: Since the beginning of the COVID-19 pandemic, several SARS-CoV-2 variants have sequentia...
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was fi...
We investigated the kinetics of the neutralizing antibody responses to the severe acute respiratory ...
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was fi...
The wide spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with phen...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
The SARS-CoV-2 B.1.617 lineage variants, Kappa (B.1.617.1) and Delta (B.1.617.2, AY) emerged during ...
Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity again...
Vaccines are proving to be highly effective in controlling hospitalisation and deaths associated wit...
Exposure histories to SARS-CoV-2 variants and vaccinations will shape the specificity of antibody re...
The Delta variant raised concern regarding its ability to evade SARS-CoV-2 vaccines. We evaluated a ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...
International audienceThe SARS-CoV-2 B.1.617 lineage was identified in October 2020 in India1,2,3,4,...
Introduction: COVID-19 vaccines have been developed to compact the current SARS-CoV-2 pandemic and h...
Background: Since the beginning of the COVID-19 pandemic, several SARS-CoV-2 variants have sequentia...
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was fi...
We investigated the kinetics of the neutralizing antibody responses to the severe acute respiratory ...
The B.1.617.2 (Delta) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was fi...
The wide spectrum of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants with phen...
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Delta variant (B.1.617.2) was the p...
The SARS-CoV-2 B.1.617 lineage variants, Kappa (B.1.617.1) and Delta (B.1.617.2, AY) emerged during ...
Virus-like particle (VLP) and live virus assays were used to investigate neutralizing immunity again...
Vaccines are proving to be highly effective in controlling hospitalisation and deaths associated wit...
Exposure histories to SARS-CoV-2 variants and vaccinations will shape the specificity of antibody re...
The Delta variant raised concern regarding its ability to evade SARS-CoV-2 vaccines. We evaluated a ...
As the SARS-CoV-2 pandemic evolves, new variants continue to emerge. Some highly transmissible varia...
This study aims to analyze the serum neutralization capacity against Delta and Omicron variants in t...